Skip to content

Randomised controlled trial of adjuvant promethazine for the relief of the pain of renal colic.

Randomised controlled trial of adjuvant promethazine for the relief of the pain of renal colic.

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000376246
Enrollment
100
Registered
2009-05-28
Start date
2009-07-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Kidney stones [renal colic] can be a very painful condition. Current recommendations suggest non-steroidal anti-inflammatory agents [e.g. ketorolac, indomethacin] as first line treatment, although it is recognised that many patients also need strong painkillers such as morphine. A recent report has suggested that anti-histamine drugs [such as promethazine] may also be effective. The aim of this study is to compare the combination of promethazine/ indomethacin/ morphine against indomethacin/ morphine on the amount of pain reported and total dose of morphine needed for patients with kidney stone pain.

Interventions

Randomised to adjuvant promethazine 25mg IV single dose or not, in addition to non-steroidal anti-inflammatory drug [NSAID] [indomethacin 100mg oral or per rectum [PR]] and morphine 2.5mg intravenous [IV], with additional 2.5mg increments at 10 minutely intervals as required.

Sponsors

Western Health
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Adults aged 18-60 with clinical diagnosis of renal colic, confirmed by computed tomography scan within 48 hours of presentation

Exclusion criteria

Allergy to anti-histamines, NSAIDS, morphine Unable to consent Hypotension bllod pressure [BP] <100 Active peptic ulcer disease

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026